These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 23453986)

  • 1. Mechanism-based testing strategy using in vitro approaches for identification of thyroid hormone disrupting chemicals.
    Murk AJ; Rijntjes E; Blaauboer BJ; Clewell R; Crofton KM; Dingemans MM; Furlow JD; Kavlock R; Köhrle J; Opitz R; Traas T; Visser TJ; Xia M; Gutleb AC
    Toxicol In Vitro; 2013 Jun; 27(4):1320-46. PubMed ID: 23453986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening chemicals for thyroid-disrupting activity: A critical comparison of mammalian and amphibian models.
    Pickford DB
    Crit Rev Toxicol; 2010 Nov; 40(10):845-92. PubMed ID: 20684730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental effect assessment for sexual endocrine-disrupting chemicals: Fish testing strategy.
    Knacker T; Boettcher M; Frische T; Rufli H; Stolzenberg HC; Teigeler M; Zok S; Braunbeck T; Schäfers C
    Integr Environ Assess Manag; 2010 Oct; 6(4):653-62. PubMed ID: 20872646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of research on assays to characterize thyroid toxicants.
    Zoeller RT; Tan SW
    Crit Rev Toxicol; 2007; 37(1-2):195-210. PubMed ID: 17364709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternatives to in vivo tests to detect endocrine disrupting chemicals (EDCs) in fish and amphibians--screening for estrogen, androgen and thyroid hormone disruption.
    Scholz S; Renner P; Belanger SE; Busquet F; Davi R; Demeneix BA; Denny JS; Léonard M; McMaster ME; Villeneuve DL; Embry MR
    Crit Rev Toxicol; 2013 Jan; 43(1):45-72. PubMed ID: 23190036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental thyroid hormone disruption: prevalence, environmental contaminants and neurodevelopmental consequences.
    Gilbert ME; Rovet J; Chen Z; Koibuchi N
    Neurotoxicology; 2012 Aug; 33(4):842-52. PubMed ID: 22138353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FIFRA Subdivision F testing Guidelines: are these tests adequate to detect potential hormonal activity for crop protection chemicals? Federal Insecticide, Fungicide, and Rodenticide Act.
    Stevens JT; Tobia A; Lamb JC; Tellone C; O'Neal F
    J Toxicol Environ Health; 1997 Apr; 50(5):415-31. PubMed ID: 9140462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating basic research on thyroid hormone action into screening and testing programs for thyroid disruptors.
    Tan SW; Zoeller RT
    Crit Rev Toxicol; 2007; 37(1-2):5-10. PubMed ID: 17364703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk assessment of endocrine active chemicals: identifying chemicals of regulatory concern.
    Bars R; Fegert I; Gross M; Lewis D; Weltje L; Weyers A; Wheeler JR; Galay-Burgos M
    Regul Toxicol Pharmacol; 2012 Oct; 64(1):143-54. PubMed ID: 22735369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid disrupting chemicals: mechanisms and mixtures.
    Crofton KM
    Int J Androl; 2008 Apr; 31(2):209-23. PubMed ID: 18217984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid effects of endocrine disrupting chemicals.
    Boas M; Feldt-Rasmussen U; Main KM
    Mol Cell Endocrinol; 2012 May; 355(2):240-8. PubMed ID: 21939731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing for thyroid hormone disruptors, a review of non-mammalian in vivo models.
    Couderq S; Leemans M; Fini JB
    Mol Cell Endocrinol; 2020 May; 508():110779. PubMed ID: 32147522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removing Critical Gaps in Chemical Test Methods by Developing New Assays for the Identification of Thyroid Hormone System-Disrupting Chemicals-The ATHENA Project.
    Kortenkamp A; Axelstad M; Baig AH; Bergman Å; Bornehag CG; Cenijn P; Christiansen S; Demeneix B; Derakhshan A; Fini JB; Frädrich C; Hamers T; Hellwig L; Köhrle J; Korevaar TIM; Lindberg J; Martin O; Meima ME; Mergenthaler P; Nikolov N; Du Pasquier D; Peeters RP; Platzack B; Ramhøj L; Remaud S; Renko K; Scholze M; Stachelscheid H; Svingen T; Wagenaars F; Wedebye EB; Zoeller RT
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32354186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncertainties for endocrine disrupters: our view on progress.
    Daston GP; Cook JC; Kavlock RJ
    Toxicol Sci; 2003 Aug; 74(2):245-52. PubMed ID: 12730617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk assessment of 'endocrine substances': guidance on identifying endocrine disruptors.
    Lewis RW
    Toxicol Lett; 2013 Dec; 223(3):287-90. PubMed ID: 24036001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing uncertainty in risk assessment by using specific knowledge to replace default options.
    McClellan RO
    Drug Metab Rev; 1996; 28(1-2):149-79. PubMed ID: 8744594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Science based guidance for the assessment of endocrine disrupting properties of chemicals.
    Bars R; Broeckaert F; Fegert I; Gross M; Hallmark N; Kedwards T; Lewis D; O'Hagan S; Panter GH; Weltje L; Weyers A; Wheeler JR; Galay-Burgos M
    Regul Toxicol Pharmacol; 2011 Feb; 59(1):37-46. PubMed ID: 20858523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.